Bruker Corporation
BRKRNASDAQHealthcare● Active
$57.59
+$1.20(+2.13%)
Market Cap$8.8B
P/E Ratio—
52W High$63.02
52W Low$28.53
Bruker Corporation (BRKR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BRKR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.31
Est. $0.23 · +34.8%
Revenue
$0.82B
Est. $0.80B · +3.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
BRKR reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.46
Rev. $3.65B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.46
Rev. Est.$3.65B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.40 | — | — | — | $0.85B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $0.23 | $0.31 | +34.8% | $0.82B | $0.80B | +3.5% |
| ▼ Q1 FY2026 | Feb 12, 2026 | $0.65 | $0.59 | -9.2% | $0.98B | $0.96B | +1.6% |
| ▲ Q4 FY2025 | Nov 3, 2025 | $0.33 | $0.60 | +81.8% | $0.86B | $0.96B | -10.8% |
| ▼ Q3 FY2025 | Aug 4, 2025 | $0.33 | $0.32 | -3.0% | $0.80B | $0.81B | -1.6% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.46 | $0.47 | +2.2% | $0.80B | $0.82B | -2.3% |
| ▲ Q1 FY2025 | Feb 13, 2025 | $0.75 | $0.76 | +1.3% | $0.98B | $0.97B | +1.4% |
| ▼ Q4 FY2024 | Nov 5, 2024 | $0.61 | $0.60 | -1.6% | $0.86B | $0.86B | +0.6% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.40
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$0.31
EPS Est.
$0.23
EPS Surpr.
+34.8%
Revenue
$0.82B
Q1 FY2026
Feb 12, 2026Miss
EPS Actual
$0.59
EPS Est.
$0.65
EPS Surpr.
-9.2%
Revenue
$0.98B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
$0.60
EPS Est.
$0.33
EPS Surpr.
+81.8%
Revenue
$0.86B
Q3 FY2025
Aug 4, 2025Miss
EPS Actual
$0.32
EPS Est.
$0.33
EPS Surpr.
-3.0%
Revenue
$0.80B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.47
EPS Est.
$0.46
EPS Surpr.
+2.2%
Revenue
$0.80B
Q1 FY2025
Feb 13, 2025Beat
EPS Actual
$0.76
EPS Est.
$0.75
EPS Surpr.
+1.3%
Revenue
$0.98B
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
$0.60
EPS Est.
$0.61
EPS Surpr.
-1.6%
Revenue
$0.86B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.85 | $0.86 | $0.87 | 5 |
| Q3 FY2028 | $0.73 | $0.74 | $0.75 | 5 |
| Q2 FY2028 | $0.70 | $0.71 | $0.72 | 6 |
| Q1 FY2028 | $0.66 | $0.67 | $0.68 | 3 |
| Q4 FY2027 | $0.84 | $0.85 | $0.86 | 2 |
| Q3 FY2027 | $0.61 | $0.62 | $0.63 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.1B | $1.1B | $1.1B | 2 |
| Q3 FY2028 | $1.0B | $1.0B | $1.0B | 2 |
| Q2 FY2028 | $0.9B | $0.9B | $0.9B | 2 |
| Q1 FY2028 | $0.9B | $0.9B | $0.9B | 2 |
| Q4 FY2027 | $1.1B | $1.1B | $1.1B | 3 |
| Q3 FY2027 | $0.9B | $0.9B | $1.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +34.8% | $38.01 | $42.30 | +11.29% |
| ▼ Q1 FY2026 | Feb 12, 2026 | -9.2% | $42.43 | $37.51 | -11.60% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +81.8% | $38.94 | $38.71 | -0.59% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -3.0% | $37.99 | $34.72 | -8.61% |
| ▲ Q2 FY2025 | May 7, 2025 | +2.2% | $39.45 | $40.76 | +3.32% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +1.3% | $51.65 | $51.15 | -0.97% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -1.6% | $59.35 | $61.34 | +3.35% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +0.0% | $63.54 | $62.16 | -2.17% |
Q2 FY2026+11.29%
Report Date
May 6, 2026
EPS Beat/Miss
+34.8%
Price Before
$38.01
Price After
$42.30
Q1 FY2026-11.60%
Report Date
Feb 12, 2026
EPS Beat/Miss
-9.2%
Price Before
$42.43
Price After
$37.51
Q4 FY2025-0.59%
Report Date
Nov 3, 2025
EPS Beat/Miss
+81.8%
Price Before
$38.94
Price After
$38.71
Q3 FY2025-8.61%
Report Date
Aug 4, 2025
EPS Beat/Miss
-3.0%
Price Before
$37.99
Price After
$34.72
Q2 FY2025+3.32%
Report Date
May 7, 2025
EPS Beat/Miss
+2.2%
Price Before
$39.45
Price After
$40.76
Q1 FY2025-0.97%
Report Date
Feb 13, 2025
EPS Beat/Miss
+1.3%
Price Before
$51.65
Price After
$51.15
Q4 FY2024+3.35%
Report Date
Nov 5, 2024
EPS Beat/Miss
-1.6%
Price Before
$59.35
Price After
$61.34
Q3 FY2024-2.17%
Report Date
Aug 6, 2024
EPS Beat/Miss
+0.0%
Price Before
$63.54
Price After
$62.16
Avg Beat Reaction+2.18%
Avg Miss Reaction-5.62%
Beat Rate5 / 8 quarters
Largest Move-11.60% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BRKR ends December
Bruker Corporation (BRKR) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.31 — beating the analyst consensus of $0.23 by +34.8%. The next BRKR earnings date is expected around September 1, 2026.
Each quarter, investors track BRKR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BRKR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BRKR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BRKR earnings · 5 questionsBruker Corporation's next earnings report is expected around September 1, 2026. BRKR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BRKR historically reports after market close (AMC).
BRKR earnings datewhen is BRKR earningsBRKR next earnings datewhen does BRKR report earningsBRKR earnings calendar
▸ Source: FMP · Bruker Corporation SEC filings · US GAAP · Bruker Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026